Trial NCT02155634

View at ClinicalTrials.gov 
Org. Study IDs: CC-5013-MM-027

Last trial update was posted on 2018-04-10

MeSH Interventions

Lenalidomide

MeSH Conditions

Blood Protein Disorders Hematologic Diseases Multiple Myeloma Neoplasms, Plasma Cell Paraproteinemias

Other Conditions

Neoplasms Plasma Cells Therapeutic Uses

Stopping Reasons

The study was terminated due to poor feasibility and lack of interest at the participating sites.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID